化多碳酸盐的生物转化和生物化由Acetobacterium物种进行
bioRxiv : the preprint server for biology
|February 6, 2026
概括
某些化per-和多醇基物质 (Cl-PFAS) 可以被Acetobacterium物种生物降解. 这项研究确定了特定的Cl-PFAS脱路径和参与该过程的潜在酶.
科学领域:
- 环境化学环境化学
- 微生物学 微生物学
- 生物修复是一种生物修复.
背景情况:
- 化per-和多醇基物质 (Cl-PFAS) 是新出现的污染物和遗留PFAS的替代品.
- 它们的环境命运,特别是生物降解性,在很大程度上是未知的.
- 以前的研究表明,微生物群落对Cl-PFAS进行无氧生物化.
研究的目的:
- 通过纯微生物培养来研究Cl-PFAS的生物化.
- 为了确定可脱的特定Cl-PFAS.
- 阐明参与Cl-PFAS生物降解的微生物途径和酶.
主要方法:
- 检查十种Cl-PFAS通过纯种植物进行脱,包括Acetobakterium bakii.
- 对转化产品的分析,以提出生物降解途径.
- 在无氧条件下对酶活性进行测定.
- 使用RNA测序的差异基因表达分析.
主要成果:
- 在10个测试的Cl-PFAS中,有6个经过了由Acetobacterium bakii.显著的脱.
- 几种Acetobacterium物种有效地除了3,5,7,8-四-2,2,3,4,4,5,6,6,7,8,8-不甲酸 (CTFE4),去除了超过50%的有机.
- 克洛斯特里同opropionicum没有除CTFE4.4.
- 参与CTFE4脱和脱的酶需要无氧条件.
- RNA测序表明,与维生素B12相关的酶在CTFE4脱过程中起着作用.
结论:
- 乙细菌物种具有生物降解特定Cl-PFAS的能力,包括CTFE4.
- 生物降解过程是无氧的,可能涉及维生素B12依赖的酶.
- 这些发现有助于了解Cl-PFAS的环境命运和潜在的生物修复策略.
更多相关视频
06:46Whole-Genome Deoxyribonucleic Acid Extraction from Mycobacterium Species via the Cetyltrimethylammonium Bromide Technique
Published on: December 12, 2025
911
07:07Controlled-release of Chlorine Dioxide in a Perforated Packaging System to Extend the Storage Life and Improve the Safety of Grape Tomatoes
Published on: April 7, 2017
11.6K
相关概念视频
Drug Biotransformation: Overview
3.8K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.8K
Drug Biotransformation: Overview
2.7K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.7K
What is a Species?
50.4K
Overview
50.4K
Keystone Species
24.9K
Measures of species biodiversity, such as richness (i.e., the number of species present) and evenness (i.e., their relative abundance), describe an ecological community’s structure. Many factors affect community structure, including abiotic factors (e.g., sunlight and nutrients), disturbances (e.g., fire or flood), species interactions (e.g., predation or competition), and chance events (e.g., foreign species invasion). Certain species—such as keystone species—also play a...
24.9K
Formation of Species
45.3K
Speciation describes the formation of one or more new species from one or sometimes multiple original species. The resulting species are discrete from the parent species, and barriers to reproduction will typically exist. There are two primary mechanisms, speciation with and without geographic isolation—allopatric and sympatric speciation, respectively.
45.3K
Factors Affecting Drug Biotransformation: Biological
608
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
608
